Market Closed -
Other stock markets
|
Pre-market 02:00:12 am | |||
208.7 EUR | +6.21% | 212.6 | +1.87% |
Apr. 23 | SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating | ZD |
Apr. 22 | Sartorius Stedim: in the red with brokerage comments | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.86% | 21.73B | |
-2.25% | 187B | |
-1.32% | 108B | |
-3.92% | 67.71B | |
+7.99% | 53.07B | |
+15.74% | 47.36B | |
+5.79% | 39.73B | |
+10.81% | 28.56B | |
+2.34% | 26.55B | |
+15.73% | 25.13B |
- Stock Market
- Equities
- DIM Stock
- News Sartorius Stedim Biotech
- Sartorius Stedim Biotech Posts 77% Surge In H1 Profit On Organic Sales Revenue Growth; Confirms FY22 Outlook